Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors

Neurosurgical Focus

Volumn 36, Issue 2, 2014, Pages

  Millesi, Matthias ^a   Kiesel, Barbara ^a   Woehrer, Adelheid ^a,b   Hainfellner, Johannes A ^a,b   Novak, Klaus ^a   Martínez Moreno, Mauricio ^a   Wolfsberger, Stefan ^a   Knosp, Engelbert ^a   Widhalm, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 ALA; PpIX fluorescence; Residual fluorescing tumor; Spinal tumor

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MICROSURGERY; MIDDLE AGED; NEUROSURGERY; PROSPECTIVE STUDY; SPINAL CORD TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEMALE; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PROSPECTIVE STUDIES; SPINAL CORD NEOPLASMS; YOUNG ADULT;

EID: 84894235477     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.12.FOCUS13485     Document Type: Article

References (47)

1. Benes V III, Barsa P, Benes V Jr, Suchomel P: Prognostic factors in intramedullary astrocytomas: a literature review. Eur Spine J 18:1397-1422, 2009.
2. Chae MP, Song SW, Park SH, Park CK: Experience with 5-aminolevulinic acid in fluorescence-guided resection of a deep sylvian meningioma. J Korean Neurosurg Soc 52:558- 560, 2012.
3. Choi D, Crockard A, Bunger C, Harms J, Kawahara N, Mazel C, et al: Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 19:215-222, 2010.
4. Coluccia D, Fandino J, Fujioka M, Cordovi S, Muroi C, Landolt H: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir (Wien) 152:1711-1719, 2010.
5. Eicker SO, Floeth FW, Kamp M, Steiger HJ, Hänggi D: The impact of fluorescence guidance on spinal intradural tumour surgery. Eur Spine J 22:1394-1401, 2013.
6. Engelhard HH, Villano JL, Porter KR, Stewart AK, Barua M, Barker FG II, et al: Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. Clinical article. J Neurosurg Spine 13:67-77, 2010.
7. Ewelt C, Stummer W, Klink B, Felsberg J, Steiger HJ, Sabel M: Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg 112:357-361, 2010.
8. Haj-Hosseini N, Richter J, Andersson-Engels S, Wårdell K: Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med 42:9-14, 2010.
9. Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, et al: Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery 67:1622-1631, 2010.
10. Hanbali F, Fourney DR, Marmor E, Suki D, Rhines LD, Weinberg JS, et al: Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery 51:1162-1174, 2002.
11. Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AE, Barnholtz-Sloan JS: Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. Clinical article. J Neurosurg Spine 14:742-747, 2011.
12. Inoue T, Endo T, Nagamatsu K, Watanabe M, Tominaga T: 5-aminolevulinic acid fluorescence-guided resection of intramedullary ependymoma: report of 9 cases. Neurosurgery 72 (2 Suppl Operative):159-168, 2012.
13. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K: Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo) 47:53-57, 2007.
14. Kajimoto Y, Kuroiwa T, Miyatake SI, Ichioka T, Miyashita M, Tanaka H, et al: Use of 5-aminolevulinic acid in fluorescenceguided resection of meningioma with high risk of recurrence. Case report. J Neurosurg 106:1070-1074, 2007.
15. Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, et al: 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154:223-228, 2011.
16. Klekamp J: Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results. Clinical article. J Neurosurg Spine 19:12-26, 2013.
17. Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF: Surgical technique and outcomes in the treatment of spinal cord ependymomas, part 1: intramedullary ependymomas. Neurosurgery 68 (1 Suppl Operative):57-63, 2011.
18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press, 2007.
19. McCormick PC, Torres R, Post KD, Stein BM: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523-532, 1990.
20. McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI: Extent of surgical resection of malignant malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 63:55-61, 2008.
21. Moon KY, Chung CK, Jahng TA, Kim HJ, Kim CH: Postoperative survival and ambulatory outcome in metastatic spinal tumors: prognostic factor analysis. J Korean Neurosurg Soc 50:216-223, 2011.
22. Moore GE, Peyton WT, French LA, Walker WW: The clinical use of fluorescein in neurosurgery. The localization of brain tumors. J Neurosurg 5:392-398, 1948.
23. Muroi C, Fandino J, Coluccia D, Berkmann S, Fathi AR, Landolt H: 5-aminolevulinic acid fluorescence-guided surgery for spinal meningioma. World Neurosurg 80:223.e1- 223.e3, 2012.
24. Mut M, Schiff D, Shaffrey ME: Metastasis to nervous system: spinal epidural and intramedullary metastases. J Neurooncol 75:43-56, 2005.
25. Nagpal S, Clarke JL: Neoplastic myelopathy. Semin Neurol 32:137-145, 2012.
26. Novak K, Widhalm G, de Camargo AB, Perin N, Jallo G, Knosp E, et al: The value of intraoperative motor evoked potential monitoring during surgical intervention for thoracic idiopathic spinal cord herniation. Clinical article. J Neurosurg Spine 16:114-126, 2012.
27. Obwegeser A, Jakober R, Kostron H: Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. Br J Cancer 78:733-738, 1998.
28. Rapp M, Klingenhöfer M, Felsberg J, Steiger HJ, Stummer W, Sabel M: Fluorescence-guided resection of spinal metastases of malignant glioma: report of 2 cases. J Neurol Surg A Cent Eur Neurosurg 73:103-105, 2011.
29. Regelsberger J, Fritzsche E, Langer N, Westphal M: Intraoperative sonography of intra- and extramedullary tumors. Ultrasound Med Biol 31:593-598, 2005.
30. Sala F, Palandri G, Basso E, Lanteri P, Deletis V, Faccioli F, et al: Motor evoked potential monitoring improves outcome after surgery for intramedullary spinal cord tumors: a historical control study. Neurosurgery 58:1129-1143, 2006.
31. Schellinger KA, Propp JM, Villano JL, McCarthy BJ: Descriptive epidemiology of primary spinal cord tumors. J Neurooncol 87:173-179, 2008.
32. Schwartz TH, McCormick PC: Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 47:211-218, 2000.
33. Shimizu S, Utsuki S, Sato K, Oka H, Fujii K, Mii K: Photodynamic diagnosis in surgery for spinal ependymoma. Case illustration. J Neurosurg Spine 5:380, 2006.
34. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93: 1003-1013, 2000.
35. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392- 401, 2006.
36. Stummer W, Stepp H, Möller G, Ehrhardt A, Leonhard M, Reulen HJ: Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) 140:995-1000, 1998.
37. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, et al: In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45:160-169, 1998.
38. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, et al: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518-526, 1998.
39. Tarapore PE, Modera P, Naujokas A, Oh MC, Amin B, Tihan T, et al: Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients. Neurosurgery 73: 247-255, 2013.
40. Valdés PA, Bekelis K, Harris BT, Wilson BC, Leblond F, Kim A, et al: 5-aminolevulinic-acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo. Neurosurgery [epub ahead of print], 2013.
41. Valdés PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, et al: Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. Clinical article. J Neurosurg 115:11-17, 2011.
42. Van Goethem JW, van den Hauwe L, Ozsarlak O, De Schepper AM, Parizel PM: Spinal tumors. Eur J Radiol 50:159- 176, 2004.
43. Widhalm G, Kiesel B, Woehrer A, Traub-Weidinger T, Preusser M, Marosi C, et al: 5-aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of diffusely infiltrating gliomas. PLoS ONE 8:e76988, 2013.
44. Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, et al: Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev 35:381-391, 2012.
45. Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, et al: 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 116:1545-1552, 2010.
46. Yang S, Yang X, Hong G: Surgical treatment of one hundred seventy-four intramedullary spinal cord tumors. Spine (Phila Pa 1976) 34:2705-2710, 2009.
47. Zhou H, Miller D, Schulte DM, Benes L, Bozinov O, Sure U, et al: Intraoperative ultrasound assistance in treatment of intradural spinal tumours. Clin Neurol Neurosurg 113:531-537, 2011.